Foundayos approval was backed by a phase 3 program called the ATTAIN trials, which enrolled over 4,500 participants across two large global studies
The most common gastrointestinal side effects of Wegovy include nausea (affecting 20-44% of patients), diarrhoea, constipation, vomiting, abdominal pain, and dyspepsia
The first subnetwork contains predominantly immune genes, such as EGFR, ALB, AGER, HP, GPX1, CD19, etc., and the second subnetwork contains Wnt and cellcell junction associated genes, including CTNNB1, AGRN, RSPO1, and DKK1
Metabolic dysregulation may exacerbate immune imbalance by altering the cellular differentiation trajectories and functional states
Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis